A protein derived from ticks enhances the effectiveness of antibiotic treatment for methicillin-resistant Staphylococcus aureus, or MRSA, according to a Yale-led study. The strategy of using the protein in combination with existing treatments can help address the growing challenge of antibiotic-resistant MRSA and other staph infections, the researchers said.